FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Genmab BLA OKd for Large B-cell Lymphoma

FDA grants Genmab an accelerated approval for its BLA for Epkinly (epcoritamab-bysp) injection for treating adult patients with relapsed or refractory...

latest-news-card-1
Biologics

Topical Gene Therapy for Wounds Approved

FDA approves a Krystal Biotech BLA for Vyjuvek, a herpes-simplex virus type 1 vector-based gene therapy for treating wounds in patients older than six...

latest-news-card-1
Medical Devices

Bionic Pancreas Cleared by FDA

FDA clears a Beta Bionics 510(k) for its Bionic Pancreas for treating Type 1 diabetes in patients aged six years and older.

latest-news-card-1
Human Drugs

Revoke Approval for MSNs Generic Hetlioz: Vanda

Vanda calls on FDA to revoke its approval of an MSN Pharmaceuticals ANDA for generic Hetlioz because it says the ANDA does not demonstrate bioequivale...

latest-news-card-1
Human Drugs

Nephron Pharmaceuticals Warehouse FDA-483

FDA releases the form FDA-483 issued following an inspection at the Nephron Pharmaceuticals warehouse in Murray, KY.

latest-news-card-1
Human Drugs

AbbVie Gets Rinvoq OK for Crohns

FDA approves AbbVies Rinvoq (upadacitinib) for treating adults with moderately to severely active Crohns disease.

latest-news-card-1
Human Drugs

Abbott Insertable Cardiac Monitor Cleared

FDA clears an Abbott 510(k) for its Assert-IQ insertable cardiac monitor for diagnosing and long-term monitoring of people experiencing arrhythmias.

latest-news-card-1
Medical Devices

Draeger Recalls Seattle CPAP Device and Components

Draeger Medical recalls its Seattle PAP Plus continuous positive airway pressure device and VentStar breathing components due to breathing circuit con...

latest-news-card-1
Federal Register

Draft Guide on Pediatric Drug Development

Federal Register notice: FDA releases a draft guidance entitled Pediatric Drug Development Under the Pediatric Research Equity Act and the Best Pharma...

latest-news-card-1
Federal Register

Pediatric Drug Exclusivity Draft Guidance

Federal Register notice: FDA makes available a draft guidance on how to qualify for pediatric drug exclusivity.